| Article Access Statistics | | | Viewed | 7316 | | | Printed | 478 | | | Emailed | 0 | | | PDF Downloaded | 30 | | | Comments | [Add] | | | Cited by others | 6 | | |
|
Click on image for details.
|
|
| ADR REPORT |
|
|
|
| Year : 2010 | Volume
: 56
| Issue : 4 | Page : 305-306 |
Tardive oculogyric crisis associated with amisulpride monotherapy
DN Mendhekar1, D Lohia2, P Kataria3
1 Neuropsychiatry and Headache Clinic 10867, Pratap Nagar, New Delhi, India
2 Long Island Jewish Medical Center, New York, USA
3 Level 5 Clinic, Alma Street Centre, Fremantle Hospital, Fremantle WA 6160, Australia
| Date of Submission | 15-Aug-2009 |
| Date of Decision | 11-Jan-2010 |
| Date of Acceptance | 10-Jun-2010 |
| Date of Web Publication | 7-Oct-2010 |
Correspondence Address:
D N Mendhekar
Neuropsychiatry and Headache Clinic 10867, Pratap Nagar, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0022-3859.70947
Oculogyric crisis (OGC) is a dystonic and distressing side- effect which occurs immediately after the administration of high-potency antipsychotic drugs and is usually reported as a subtype of dystonia. We report a case of a young woman with schizophrenia who presented with tardive OGC related to amisulpride.
Keywords: Amisulpride, adverse drug reaction, oculogyric crisis, tardive dystonia
How to cite this article:
Mendhekar D N, Lohia D, Kataria P. Tardive oculogyric crisis associated with amisulpride monotherapy. J Postgrad Med 2010;56:305-6 |
A 22-year-old female who had no personal or family history of neurological or movement disorder was diagnosed as a case of paranoid schizophrenia (duration eight months) as per DSM IV criteria. Treatment was initiated with tablet amisulpride 100 mg/d. The dose was later increased to 400 mg/d over four weeks with moderate improvement in her psychotic symptoms. At Week 18 of amisulpride 400 mg therapy, she developed up rolling of eyeballs and it was so obvious that only her sclera could be visible. She had to make an effort to blink. Voluntarily she could control up rolling of her eyes for 1-2 min. This phenomenon would occur once every two to three days mainly in the evenings and would last for 2-3 h. She would get extremely distressed and anxious during this period. Initially, relatives tried to reassure her in order to calm her down. Given the spontaneous remission of the episodes, they later interpreted her symptoms as an attention-seeking behavior. Careful assessment did not reveal any evidence of psychological gain and she continued to complain about these symptoms. Neurological examination did not show any additional findings and no abnormal movements were noticed in other parts of the body. The brain magnetic resonance imaging (MRI) and electroencephalogram (EEG) did not reveal any abnormality. She was not treated with any other psychotropic drugs. There was no exacerbation of her psychotic illness during this period. Two weeks after the onset of this adverse event, trihexiphenidyl 6 mg/d was added without any improvement. Subsequently, trihexiphenidyl and amisulpride were replaced by clozapine 25 mg/d increasing to 200 mg/d over a period of four weeks with complete amelioration of these adverse events. She experienced this distressing symptom for a total of four months.
The temporal relation between treatment with amisulpride and occurrence of OGC suggests that tardive OGC may be attributable to amisulpride. The Naranjo adverse drug reaction probability scale indicated a 'probable' relationship between OGC and amisulpride therapy in this patient. [1] Whereas other atypical neuroleptics such as clozapine [2],[3] olanzapine [4] and aripiprazole [5] have been implicated in the induction of tardive OGC, the association of tardive OGC with amisulpride has not yet been reported. To the best of our knowledge, there are very few reported cases of tardive dystonia (TDt) and tardive dyskinesia (TD) with amisulpride therapy. Previously reported two cases suffering from schizophrenia developed TD while on 400 mg/d and 800 mg/d of amisulpride therapy respectively [6],[7] and one case developed TDt while on low-dose amisulpride (200 mg/d). [8] Acute onset oculogyric crisis has also been reported with this drug [9] but ours is the first report of a tardive OGC associated with amisulpride. The pathophysiology of tardive OGC is not fully understood. Amisulpride is an alkylsulphone derivative of the substituted benzamide, with high affinity for presynaptic D2/D3 receptors. At low dosages (100-300 mg/day), amisulpride binds preferentially to D2/D3 presynaptic autoreceptors, increasing dopaminergic transmission in the prefrontal cortex, whereas dosages between 400-800 mg/day result in antagonism of postsynaptic dopamine receptors. [10] Blockade of dopamine postsynaptic receptors at higher dosages could be the best possible explanation for the occurrence of this rare adverse event.
| :: References | |  |
| 1. | Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.  [PUBMED] |
| 2. | Dave M. Tardive oculogyric crisis with clozapine. J Clin Psychiatry 1994;55:264-5. [PUBMED] |
| 3. | Uzun O, Doruk A. Tardive oculogyric crisis during treatment with clozapine: Report of three cases. Clin Drug Investig 2007;27:861-4. [PUBMED] [FULLTEXT] |
| 4. | Vaiha VN, Naik PM, Deotale P. Unusual case reports: Tardive oculogyric crisis (tardive syndromes). Indian J Psychiatry 2007;49:219-20. |
| 5. | Lim HK, Pae CU, Lee C, Lee CU. Tardive dystonic symptoms associated with aripiprazole treatment. Prog Neuropsychopharmacol Biol Psychiatry 2008:15;32:589-90. |
| 6. | Fountoulakis KN, Panagiotidis P, Siamouli M, Kantartzis S, Mavridis T, Lacovides A, et al. Amisulpride-induced tardive dyskinesia. Schizophr Res 2006;88:232-4. |
| 7. | Masdrakis VG, Papadimitriou GN, Papageorgiou C, Kouzoupis A, Giailoglou D, Soldatos CR. Development of tardive dyskinesia in a patient taking amisulpride. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:586-7. [PUBMED] [FULLTEXT] |
| 8. | Sevincok L, Balci V, Akyildiz U. Tardive dystonia associated with low-dose of amisulpride: A case report. J Clin Psychopharmacol 2008;28:573-4. [PUBMED] [FULLTEXT] |
| 9. | Mendhekar DN, Yajuvendra B, Aggarwal A. Amisulpride-induced both oculogyric crisis and trismus. Indian J Med Sci 2009;62:239-41. |
| 10. | Mφller HJ. Amisulpride: Limbic specificity and the mechanism of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:1101-11. |
| This article has been cited by | | 1 |
A case of metoclopramide-induced oculogyric crisis in a schizophrenic patient under anticholinergic therapy |
|
| Hülya ERTEKIN, Begüm Aygen GÜMÜS | | FAMILY PRACTICE AND PALLIATIVE CARE. 2022; : 142 | | [Pubmed] | [DOI] | | | 2 |
Antipsychotic induced chronic recurrent oculogyric crisis in a patient with obsessive compulsive disorder |
|
| Rishab Gupta,Yatan Pal Singh Balhara | | Psychopharmacology. 2014; | | [Pubmed] | [DOI] | | | 3 |
Oculogyric crisis with psychotic exacerbation after amisulpiride cessation: A case report [Amisülpirid kesilmesini i̇zleyen okülerjik krizin eşlik ettiǧi psikotik alevlenme: Olgu sunumu] |
|
| Özcan, S. and Tamam, L. and Soydan, A. | | Noropsikiyatri Arsivi. 2013; 50(2): 186-188 | | [Pubmed] | | | 4 |
Medication-related oculogyric crises: A description of four cases and a review of the literature [Crisis oculógiras asociadas a fármacos: Descripción de cuatro casos y revisión de la bibliografÃa] |
|
| Darling, A. and Póo, P. and Pérez-Dueñas, B. and Campistol, J. | | Revista de Neurologia. 2013; 56(3): 152-156 | | [Pubmed] | | | 5 |
Cefixime-induced oculogyric crisis |
|
| Bayram, E. and Bayram, M.T. and Hiz, S. and Turkmen, M. | | Pediatric Emergency Care. 2012; 28(1): 55-56 | | [Pubmed] | | | 6 |
Cefixime-Induced Oculogyric Crisis |
|
| Erhan Bayram,Meral Torun Bayram,Semra Hiz,Mehmet Turkmen | | Pediatric Emergency Care. 2012; 28(1): 55 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
